1. Home
  2. LXRX vs BYON Comparison

LXRX vs BYON Comparison

Compare LXRX & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • BYON
  • Stock Information
  • Founded
  • LXRX 1995
  • BYON 1997
  • Country
  • LXRX United States
  • BYON United States
  • Employees
  • LXRX N/A
  • BYON N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • LXRX Health Care
  • BYON Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • BYON Nasdaq
  • Market Cap
  • LXRX 273.9M
  • BYON 254.3M
  • IPO Year
  • LXRX 2000
  • BYON N/A
  • Fundamental
  • Price
  • LXRX $0.69
  • BYON $5.88
  • Analyst Decision
  • LXRX Buy
  • BYON Buy
  • Analyst Count
  • LXRX 2
  • BYON 10
  • Target Price
  • LXRX $6.00
  • BYON $17.00
  • AVG Volume (30 Days)
  • LXRX 5.0M
  • BYON 2.7M
  • Earning Date
  • LXRX 03-10-2025
  • BYON 02-18-2025
  • Dividend Yield
  • LXRX N/A
  • BYON N/A
  • EPS Growth
  • LXRX N/A
  • BYON N/A
  • EPS
  • LXRX N/A
  • BYON N/A
  • Revenue
  • LXRX $5,229,000.00
  • BYON $1,476,271,000.00
  • Revenue This Year
  • LXRX $842.94
  • BYON N/A
  • Revenue Next Year
  • LXRX $19.76
  • BYON $4.55
  • P/E Ratio
  • LXRX N/A
  • BYON N/A
  • Revenue Growth
  • LXRX 886.60
  • BYON N/A
  • 52 Week Low
  • LXRX $0.62
  • BYON $4.45
  • 52 Week High
  • LXRX $3.73
  • BYON $37.10
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 40.93
  • BYON 52.03
  • Support Level
  • LXRX $0.70
  • BYON $5.55
  • Resistance Level
  • LXRX $0.75
  • BYON $6.18
  • Average True Range (ATR)
  • LXRX 0.08
  • BYON 0.52
  • MACD
  • LXRX -0.00
  • BYON 0.10
  • Stochastic Oscillator
  • LXRX 7.14
  • BYON 62.78

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: